BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Deals

  Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

  Twist Bioscience Corporation today announced the closing of its upsized underwritten public offering of 5,227,272 shares of its common stock at a public offering price of $55.00 per share.

  February 15, 2022

   · 

  4 min read
• Policy

  Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year

  Certara, Inc., a global leader in biosimulation, announced that 90 percent of new drug approvals by the U.S. Food and Drug Administration’s Center for Drug Evaluation and Review were received by Certara’s customers in 2021, excluding diagnostic agents.

  February 15, 2022

   · 

  2 min read
• Business

  Coherus Names Paul Reider Chief Commercial Officer

  Coherus BioSciences, Inc. (Nasdaq: “CHRS”, “the Company”, “Coherus”) today announced Paul Reider has been named Chief Commercial Officer.

  February 15, 2022

   · 

  4 min read
• Business

  On Demand Pharmaceuticals Commissions State-of-the-Art, cGMP Medicine Manufacturing Facility

  On Demand Pharmaceuticals, Inc. announced the opening of its current Good Manufacturing Process compliant manufacturing facility dedicated to manufacturing all aspects of the medicine supply chain, from fine chemicals to final drug product.

  February 15, 2022

   · 

  4 min read
• FDA

  Rapid Medical Receives FDA Breakthrough Device Designation for Vasospasm Treatment

  Rapid Medical today announced FDA breakthrough designation for its Comaneci™ embolization assist device to facilitate the treatment of cerebral vasospasm following hemorrhagic stroke.

  February 15, 2022

   · 

  3 min read
• Business

  Radius Health to Release Fourth Quarter and Full Year 2021 Financial Results, Host Conference Call and Live Webcast on Thursday, February 24, 2022

  Radius Health, Inc. announced that it will release its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022.

  February 15, 2022

   · 

  1 min read
• Drug Development

  Inflammatory Response Research Announces Positive Data from Phase 1 Pilot Study of IRR-401 in COVID Patients

  Inflammatory Response Research, Inc. (“IRR”), a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions, today announced positive data from a Phase 1 Pilot Study of IRR-401 in COVID-19 (+) patients.

  February 15, 2022

   · 

  3 min read
• Balofloxacin Market Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2028

  The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

  February 15, 2022

   · 

  7 min read
• Cell Signaling Market Trends, Revenue, Key Players, Growth, Share and Forecast Till 2028

  The report offers detailed overview of the market with recent market dynamics and industrial status.

  February 15, 2022

   · 

  7 min read
• Self-Sampling Blood Collection and Storage Devices Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2028

  The report provides details about market size, market restraints, drivers, challenges, growth opportunities, and top companies in the market.

  February 15, 2022

   · 

  7 min read